

Professor Jude A Oben
BM, BCh(Oxon)-MD, Ph.D, FRCP, AGAF, FAASLD, SigmaXi
Consultant Gastroenterologist-Hepatologist, Obesity & Metabolic Physician
Gastroenterology and HepatologyObesity & Metabolic
GMC: 4122553
About Professor Jude A Oben
Biography
Professor Jude A Oben, is a Clinician Scientist and holds a Consultant appointment in Gastroenterology
and Hepatology at Guy’s & St Thomas’ Hospital, London. He was previously a Professor Associate in
Experimental Hepatology, Faculty of Life Sciences and Medicine, King’s College London and a Professor
Associate in Hepatology, at University College London, Institute of Liver and Digestive Health, Royal Free
Hospital, London. Prof Oben has a Ph.D in Pharmacology from University College London and
studied medicine at Oxford University (St John’s College), with a stint at Stanford University, Palo
Alto, USA, as a Research Fellow in Immunology. After his time at Oxford, his initial post-graduate medical
training was at the Royal Post-Graduate Medical School, Hammersmith Hospital, Imperial College
London, after which he commenced specialist training in Ophthalmology (Eye Surgery) from which
he changed to specialise in Gastroenterology-Hepatology.
During his specialist registrar training in Gastroenterology-Hepatology, he re-orientated his research
career with 2years as a Post-Doctoral Fellow at Johns Hopkins University, Baltimore, USA. Prof
Oben’s work at Johns Hopkins combined his previous interest in neuroscience with liver medicine and he
published extensively on the interactions between the autonomic nervous system and liver repair via liver
progenitor stem cells and liver stellate cells, in the context of Diabetic Liver Disease (Non-Alcoholic Fatty
Liver Disease, NAFLD). On the back of a very productive period at Johns Hopkins he was awarded a
Wellcome Trust Intermediate Fellowship funding on returning to London. His research has remained
productive. He is currently a Fellow of the Royal College of Physicians of London and Edinburgh; a Fellow
of the American Gastroenterological Association and a Fellow of the American Association for the Study
of Liver Diseases. He specilises in Metabolic Health especially as it applies to the Liver and Type 2 Diabetes.
